Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells
are destroyed, resulting in poor blood sugar control. The purpose of this study is to
determine the safety and effectiveness of islet transplantation, combined with
immunosuppressive medications, for treating type 1 diabetes in individuals experiencing
hypoglycemia unawareness and severe hypoglycemic episodes.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)